Page last updated: 2024-10-26

etanidazole and Cancer, Second Primary

etanidazole has been researched along with Cancer, Second Primary in 1 studies

Etanidazole: A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.
etanidazole : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitro-1H-imidazol-1-yl)acetic acid with the amino group of ethanolamine. Used as a radiosensitising agent for hypoxic tumour cells.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hall, EJ1
Hei, TK1

Other Studies

1 other study available for etanidazole and Cancer, Second Primary

ArticleYear
Oncogenic transforming potential of etanidazole.
    International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:4

    Topics: Animals; Cell Line; Cell Transformation, Neoplastic; Etanidazole; Mice; Neoplasms, Second Primary; N

1992